Co Diagnostics Stock Future Price Prediction

CODX
 Stock
  

USD 3.21  0.03  0.94%   

Co-Diagnostics stock price prediction is an act of determining the future value of Co Diagnostics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Co Diagnostics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Co Diagnostics and does not consider all of the tangible or intangible factors available from Co Diagnostics' fundamental data. We analyze noise-free headlines and recent hype associated with Co-Diagnostics, which may create opportunities for some arbitrage if properly timed.
Continue to Co Diagnostics Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Co Diagnostics based on different types of headlines from major news networks to social media. The Co Diagnostics stock price prediction module provides an analysis of price elasticity to changes in media outlook on Co Diagnostics over a specific investment horizon.Using Co Diagnostics hype-based prediction, you can estimate the value of Co-Diagnostics from the perspective of Co Diagnostics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Co Diagnostics using Co Diagnostics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Co Diagnostics using crowd psychology based on the activity and movement of Co Diagnostics' stock price.

Co Diagnostics Implied Volatility

    
  340.86  
Co Diagnostics' implied volatility exposes the market's sentiment of Co-Diagnostics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Co Diagnostics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Co Diagnostics stock will not fluctuate a lot when Co Diagnostics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Co Diagnostics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Co Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying Co Diagnostics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Co Diagnostics after-hype prediction price

    
  $ 3.06  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Co Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Co Diagnostics in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
2.677.7912.91
Details
Naive
Forecast
LowNext ValueHigh
0.0451922.267.38
Details
3 Analysts
Consensus
LowTarget PriceHigh
15.0022.0029.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.743.243.74
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Co Diagnostics. Your research has to be compared to or analyzed against Co Diagnostics' peers to derive any actionable benefits. When done correctly, Co Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Co-Diagnostics.

Co Diagnostics After-Hype Price Prediction Density Analysis

As far as predicting the price of Co Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Co Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Co Diagnostics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Co Diagnostics Estimiated After-Hype Price Volatility

In the context of predicting Co Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Co Diagnostics' historical news coverage. Co Diagnostics' after-hype downside and upside margins for the prediction period are 0.15 and 8.18, respectively. We have considered Co Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 3.21
3.06
After-hype Price
8.18
Upside
Co Diagnostics is slightly risky asset. Analysis and calculation of next after-hype price of Co-Diagnostics is based on 3 months time horizon.

Co Diagnostics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Co Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Co Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Co Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.87  5.08   0.16   0.67  9 Events / Month1 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.213.064.67 
2,822  

Co Diagnostics Hype Timeline

Co-Diagnostics is currently traded for 3.21. The entity has historical hype elasticity of -0.16 and average elasticity to hype of competition of 0.67. Co Diagnostics is forecasted to decline in value after the next headline with the price expected to drop to 3.06. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -4.67% whereas the daily expected return is currently at -0.87%. The volatility of related hype on Co Diagnostics is about 659.74% with expected price after next announcement by competition of 3.88. About 21.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.27. Some equities with similar Price to Book (P/B) outperform the market in the long run. Co-Diagnostics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days.
Continue to Co Diagnostics Basic Forecasting Models to cross-verify your projections.

Co Diagnostics Related Hype Analysis

Having access to credible news sources related to Co Diagnostics' direct competition is more important than ever and may enhance your ability to predict Co Diagnostics' future price movements. Getting to know how Co Diagnostics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Co Diagnostics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
GEGeneral Electric 0.77 9 per month 0.00  0.0129  2.90 (3.66)  10.75 

Co Diagnostics Additional Predictive Modules

Most predictive techniques to examine Co Diagnostics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Co Diagnostics using various technical indicators. When you analyze Co Diagnostics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Co Diagnostics Predictive Indicators

The successful prediction of Co Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Co-Diagnostics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Co Diagnostics based on analysis of Co Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Co Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Co Diagnostics's related companies.

Story Coverage note for Co Diagnostics

The number of cover stories for Co Diagnostics depends on current market conditions and Co Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Co Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Co Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Co Diagnostics Short Properties

Co Diagnostics' future price predictability will typically decrease when Co Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Co-Diagnostics often depends not only on the future outlook of the potential Co Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Co Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out5.10%
Short Percent Of Float5.12%
Float Shares33.84M
Average Daily Volume Last 10 Day310.23k
Shares Short Prior Month1.85M
Average Daily Volume In Three Month668.5k
Date Short Interest15th of July 2022
Continue to Co Diagnostics Basic Forecasting Models to cross-verify your projections. Note that the Co-Diagnostics information on this page should be used as a complementary analysis to other Co Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Co Diagnostics Stock analysis

When running Co-Diagnostics price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Is Co Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Co Diagnostics. If investors know Co Diagnostics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Co Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Co-Diagnostics is measured differently than its book value, which is the value of Co Diagnostics that is recorded on the company's balance sheet. Investors also form their own opinion of Co Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Co Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Co Diagnostics' market value can be influenced by many factors that don't directly affect Co Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Co Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Co Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Co Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.